Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease

Open Access

Peer-reviewed

Research Article

Sanne Bøjet Larsen,

Affiliation Department of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark
⨯
Erik Lerkevang Grove,

Affiliation Department of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark
⨯
Manan Pareek,

Affiliation Department of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark
⨯
Steen Dalby Kristensen,

Affiliations Department of Cardiology, Aarhus University Hospital, DK-8200, Aarhus N, Denmark, Faculty of Health Sciences, Aarhus University, DK-8200, Aarhus N, Denmark
⨯
Anne-Mette Hvas

* E-mail: am.hvas@dadlnet.dk

Affiliations Faculty of Health Sciences, Aarhus University, DK-8200, Aarhus N, Denmark, Department of Clinical Biochemistry, Aarhus University Hospital, DK-8200, Aarhus N, Denmark
⨯

Reader Comments (0)

Platelet aggregation
Is the Subject Area "Platelet aggregation" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Antiplatelet therapy
Is the Subject Area "Antiplatelet therapy" applicable to this article?

Thanks for your feedback.
Thromboxane
Is the Subject Area "Thromboxane" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Coronary heart disease
Is the Subject Area "Coronary heart disease" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Body mass index
Is the Subject Area "Body mass index" applicable to this article?

Thanks for your feedback.